Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines

Published:2014-05 Issue:5 Volume:19 Page:637-644
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Jin Guangxu,Wong Stephen T.C.

Funder

National Institutes of Health (NIH)

National Cancer Institute (NCI)

John S. Dunn Research Foundation

T.T. & W.F. Chao Foundation

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference67 articles.

1. Drug repositioning: identifying and developing new uses for existing drugs;Ashburn;Nat. Rev. Drug Discov.,2004

2. Challenges and opportunities of drug repositioning;Novac;Trends Pharmacol. Sci.,2013

3. Off-label use of oncology drugs: the need for more data and then some;Pfister;J. Clin. Oncol.,2012

4. Off-label use of oncology drugs: too much, too little, or just right?;Burstein;J. Natl. Compr. Canc. Netw.,2013

5. How were new medicines discovered?;Swinney;Nat. Rev. Drug Discov.,2011

Cited by 341 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential of signature-based drug repurposing for anticancer drug discovery;Archives of Biochemistry and Biophysics;2024-11

2. Advances in the approaches used to repurpose drugs for neuroblastoma;Expert Opinion on Drug Discovery;2024-09-11

3. An Overview of Computational‐Based Strategies for Drug Repositioning;Integrating Metaheuristics in Computer Vision for Real‐World Optimization Problems;2024-07-31

4. Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids;Clinical Cancer Research;2024-07-17

5. Introduction to Drug Repurposing: Exploring New Applications for Existing Drugs;Pharmaceutical Science;2024-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3